Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Personalized Medicine Coalition Submits List Of Drug Firm Nominees For PCORI Methodology Committee

This article was originally published in The Pink Sheet Daily

Executive Summary

PhRMA and BIO decline to make nominations. GAO announces replacement for PCORI board.

You may also be interested in...



PCORI Methodology Committee Member Has Interest In Cost Measures

While the legislative language that establishes the Patient-Centered Outcomes Research Institute forbids the body from using cost measures, such as dollars-per-quality adjusted life years, as a threshold in determining what type of intervention is effective or recommended, one committee member could be influential in putting a cost component into the research prioritization process.

PCORI Methodology Committee Member Has Interest In Cost Measures

While the legislative language that establishes the Patient-Centered Outcomes Research Institute forbids the body from using cost measures, such as dollars-per-quality adjusted life years, as a threshold in determining what type of intervention is effective or recommended, one committee member could be influential in putting a cost component into the research prioritization process.

Academia Dominates Appointments To PCORI Methodology Committee

Pharma industry execs nominated by Personalized Medicine Coalition fail to get seats on the committee that will set methodological standards for research conducted through the Patient-Centered Outcomes Research Institute.

Related Content

Topics

UsernamePublicRestriction

Register

PS071465

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel